secwatch / observer
8-K filed June 20, 2023, 7:59 PM ET ticker MDGL CIK 0001157601
leadership confidence high sentiment neutral materiality 0.50

Madrigal appoints Julian Baker as Chairman, adds two Baker Bros. affiliates to board

MADRIGAL PHARMACEUTICALS, INC.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

David Milligan

Class III Director
MDGL · MADRIGAL PHARMACEUTICALS, INC.
Effective
2023-06-15
Filed
June 20, 2023, 7:59 PM ET
On June 15, 2023, Keith R. Gollust and David Milligan, Ph.D., each Class III directors on the Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”), resigned from the Board, effective immediately.
Appointed

Raymond Cheong

Class III Director
MDGL · MADRIGAL PHARMACEUTICALS, INC.
Effective
2023-06-15
Filed
June 20, 2023, 7:59 PM ET
On June 15, 2023, Julian Baker and Raymond Cheong were appointed to the Board as Class III directors, effective immediately.
Departed

Keith R. Gollust

Class III Director
MDGL · MADRIGAL PHARMACEUTICALS, INC.
Effective
2023-06-15
Filed
June 20, 2023, 7:59 PM ET
On June 15, 2023, Keith R. Gollust and David Milligan, Ph.D., each Class III directors on the Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”), resigned from the Board, effective immediately.
Appointed

Julian Baker

Director and Chairman
MDGL · MADRIGAL PHARMACEUTICALS, INC.
Effective
2023-06-15
Filed
June 20, 2023, 7:59 PM ET
Julian Baker was appointed to serve as the independent Chairman of the Board of Directors.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

David Milligan resigned as Class III Director at MADRIGAL PHARMACEUTICALS, INC..

Action
resigned
Role
Class III Director
Exact text from the filing
On June 15, 2023, Keith R. Gollust and David Milligan, Ph.D., each Class III directors on the Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”), resigned from the Board, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Raymond Cheong was appointed as Class III Director at MADRIGAL PHARMACEUTICALS, INC..

Action
appointed
Role
Class III Director
Exact text from the filing
On June 15, 2023, Julian Baker and Raymond Cheong were appointed to the Board as Class III directors, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Keith R. Gollust resigned as Class III Director at MADRIGAL PHARMACEUTICALS, INC..

Action
resigned
Role
Class III Director
Exact text from the filing
On June 15, 2023, Keith R. Gollust and David Milligan, Ph.D., each Class III directors on the Board of Directors (the “Board”) of Madrigal Pharmaceuticals, Inc. (the “Company”), resigned from the Board, effective immediately.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 1.0

Julian Baker was appointed as Director and Chairman at MADRIGAL PHARMACEUTICALS, INC..

Action
appointed
Role
Director and Chairman
Exact text from the filing
Julian Baker was appointed to serve as the independent Chairman of the Board of Directors.
View on SEC.gov

MADRIGAL PHARMACEUTICALS, INC. filing history →

Source: SEC EDGAR
accession 0001193125-23-169190
view filing index on sec.gov
view primary document
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.